Flu News and Research

RSS

Pairing online patient dashboard with 'nudges' to doctors triples statin prescribing rates

Pairing an online patient dashboard with "nudges" to doctors tripled statin prescribing rates in a clinical trial led by Penn Medicine researchers.

27 Jul 2018

Discovery of strange parasitic link to entrepreneurialism

Good news for cat lovers! A latest study has found that a parasite infestation found in cat feces could make a person an entrepreneur. Cat feces commonly contain parasite Toxoplasma gondii and its infection can often go unnoticed in most individuals. A new study has found that people who have had T. gondii infection are around 1.4 times more likely to major in business studies compared to those who were not infected.

25 Jul 2018

Newly discovered mechanism may be useful target to stop flu virus from infecting cells

There's a hitch in the swing of a protein that delivers the flu virus. Rice University and Baylor College of Medicine researchers believe this mechanism may be a useful target to stop the virus from infecting cells.

24 Jul 2018

Collaborative care models have proven to improve outcomes and access to mental health care

Mental health has been in the news recently for all the wrong reasons, from unexpected celebrity suicides to a reported increase in depression diagnoses.

23 Jul 2018

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications

20 Jul 2018

Why men may recover more quickly from influenza infections than women

Men may recover more quickly from influenza infections because they produce more of a key lung-healing protein, a study from scientists at Johns Hopkins Bloomberg School of Public Health suggests.

17 Jul 2018

Associate professor receives $1 million grant for disease research

Associate Professor Janelle Ayres is the recipient of a $1 million grant from the W. M. Keck Foundation to study new ways to treat deadly infections including sepsis and the flu, both of which require novel therapies beyond antibiotics and antivirals to effectively combat.

12 Jul 2018

Children with rare skin conditions often get inconsistent and costly treatments

Researchers from the University of Illinois at Chicago are the first to conduct a large-scale analysis of treatments and outcomes for children with Stevens-Johnson syndrome and toxic epidermal necrolysis, rare skin conditions caused by medications and infections.

10 Jul 2018

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

29 Jun 2018

Scientists discover how the flu virus resets its trap

For the first time, scientists have directly visualized in real-time structural changes in the surface protein of the influenza virus that may help the virus to fuse with and enter target cells before hijacking their functions.

29 Jun 2018

Human Vaccines Project and Seqirus collaborate to accelerate universal flu vaccine research

The Human Vaccines Project, a nonprofit public-private partnership focused on decoding the immune system to improve human health, and Seqirus, a global leader in the prevention of influenza, announced today that Seqirus is joining the Project's Universal Influenza Vaccine Initiative.

28 Jun 2018

Researchers examine new influenza drug's mode of action in detail

The new influenza drug Xofluza, developed by the Japanese pharmaceutical company Shionogi, was approved for clinical use in Japan in February 2018.

26 Jun 2018

Experts witness action of influenza infection in the lungs of living mice

In the 1966 novel, Fantastic Voyage, written by biochemist and author Isaac Asimov, a crew of people become miniaturized in order to travel through the body of a scientist and save him from a blood clot in his brain.

26 Jun 2018

Blocking viral-host interaction slows down flu virus replication, study shows

Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, PhD, chair of the department of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, and doctoral student Matthew Thompson.

25 Jun 2018

New guide published to help battle fatal disease caused by kissing bugs

A guide to help battle a potentially fatal disease transferred by a blood-sucking insect called the kissing bug has been published by a task force led by The University of Texas Health Science Center at Houston.

22 Jun 2018

New study examines how the brain plays role in rheumatoid arthritis inflammation

In patients with chronic inflammatory conditions, such as rheumatoid arthritis, there has been limited understanding of how this inflammation affects the brain.

18 Jun 2018

InDevR releases first reagent kit for assessing neuraminidase in influenza vaccines

InDevR Inc. announced product release of the first ever commercial reagent kit designed explicitly for assessment of neuraminidase in influenza vaccines.

12 Jun 2018

Study shows how to slow down spread of Ebola virus

Between 2013 and 2016, West Africa suffered the most severe outbreak of Ebola ever recorded. In Guinea, Sierra Leone and Liberia, a total of 29,000 patients were diagnosed with the disease. More than 11,000 people didn't survive.

12 Jun 2018

Study: Aircraft microbiomes have much in common with those at homes and offices

What does flying in a commercial airliner have in common with working at the office or relaxing at home?According to a new study, the answer is the microbiome - the community of bacteria found in homes, offices and aircraft cabins.

8 Jun 2018

DHS accelerates development of new methods to detect emerging biothreats

Biothreats - harmful pathogens that are either naturally or deliberately released - pose a risk to national security and public health, and identifying new detection methods is a top priority for the Department of Homeland Security (DHS) Science and Technology Directorate.

8 Jun 2018

Flu News and Research

Pairing online patient dashboard with 'nudges' to doctors triples statin prescribing rates

Discovery of strange parasitic link to entrepreneurialism

Newly discovered mechanism may be useful target to stop flu virus from infecting cells

Collaborative care models have proven to improve outcomes and access to mental health care

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Why men may recover more quickly from influenza infections than women

Associate professor receives $1 million grant for disease research

Children with rare skin conditions often get inconsistent and costly treatments

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

Scientists discover how the flu virus resets its trap

Human Vaccines Project and Seqirus collaborate to accelerate universal flu vaccine research

Researchers examine new influenza drug's mode of action in detail

Experts witness action of influenza infection in the lungs of living mice

Blocking viral-host interaction slows down flu virus replication, study shows

New guide published to help battle fatal disease caused by kissing bugs

New study examines how the brain plays role in rheumatoid arthritis inflammation

InDevR releases first reagent kit for assessing neuraminidase in influenza vaccines

Study shows how to slow down spread of Ebola virus

Study: Aircraft microbiomes have much in common with those at homes and offices

DHS accelerates development of new methods to detect emerging biothreats

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News